Zobrazeno 1 - 10
of 16
pro vyhledávání: '"L L Van De Verg"'
Autor:
E. Forbes, J.H. Tian, Colleen Carpenter, Pace John L, August L. Bourgeois, W.J. Jackson, G.S. Nabors, H.H. Yang, G. Gomes, Richard I. Walker, Robin McKenzie, L L Van De Verg
Publikováno v:
Vaccine. 24:3735-3745
Orally delivered, inactivated whole-cell vaccines are safe methods of inducing local and systemic immunity. To increase surface proteins associated with adherence and invasion, Shigella sonnei were grown in BHI broth containing deoxycholate. A whole-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b9da6518eab3b9cc513e096ebd7c9c
https://doi.org/10.1016/j.vaccine.2005.07.014
https://doi.org/10.1016/j.vaccine.2005.07.014
Autor:
Edwin V. Oaks, Richard I. Walker, Kevin R. Turbyfill, August L. Bourgeois, B. Tai, Robert W. Kaminski, M. Wu, L L Van De Verg, Kristen A. Clarkson
Publikováno v:
Clinical and vaccine immunology : CVI. 21(3)
Studies were undertaken to manufacture a multivalentShigellainactivated whole-cell vaccine that is safe, effective, and inexpensive. By using several formalin concentrations, temperatures, and incubation periods, an optimized set of inactivation cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b77e272428bc0181b1221b8ee609b176
https://pubmed.ncbi.nlm.nih.gov/24403527
https://pubmed.ncbi.nlm.nih.gov/24403527
Autor:
J L Puryear, N O Bendiuk, Antoinette B. Hartman, David N. Taylor, J L Ruckert, M M Marsh, L L Van De Verg, Karen L. Kotloff
Publikováno v:
Vaccine. 14:1062-1068
To study the cross-reactivity pattern of Shigella flexneri 2a O-antigen antibodies, sera from humans and monkeys challenged with S. flexneri 2a, and from humans and guinea pigs immunized with a recombinant vaccine expressing serotype 2a O-antigen, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8532721dc827ff18da9957662c16a330
https://doi.org/10.1016/0264-410x(96)00006-0
https://doi.org/10.1016/0264-410x(96)00006-0
Autor:
T L Hadfield, Richard L. Warren, Ben D. Tall, Luther E. Lindler, L L Van De Verg, D. Hoover, N J Snellings, F A Rubin
Publikováno v:
Scopus-Elsevier
Brucella group 3 antigens (Ags) are outer membrane proteins (OMPs) with a molecular mass ranging from 25 to 30 kDa. The OMPs are of interest partially because of their potential use as vaccine and diagnostic reagents. We used human convalescent antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe6d0b85706f15b1006ae18b3c65f5b
https://doi.org/10.1128/iai.64.7.2490-2499.1996
https://doi.org/10.1128/iai.64.7.2490-2499.1996
Publikováno v:
Infection and Immunity. 63:1947-1954
A murine pulmonary model was used to study the mucosal immune response to Shigella flexneri serotype 2a infection. Inoculation of BALB/cJ mice with shigellae via the intranasal route resulted in bacterial invasion of bronchial and alveolar epithelia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26ce1b5ae4881bb6a18556da85958a81
https://doi.org/10.1128/iai.63.5.1947-1954.1995
https://doi.org/10.1128/iai.63.5.1947-1954.1995
Autor:
Richard L. Warren, Ben D. Tall, Apurba K. Bhattacharjee, Wendell D. Zollinger, Liang Yuan, David L. Hoover, K Sasala, T L Hadfield, Antoinette B. Hartman, L L Van De Verg
Publikováno v:
Scopus-Elsevier
A mucosal vaccine against brucellosis consisting of the lipopolysaccharide (LPS) of Brucella melitensis complexed with the outer membrane protein (GBOMP) of group B Neisseria meningitidis was tested in small-animal models of intranasal immunization.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de37f67761cca8881e5b472cedba6262
https://europepmc.org/articles/PMC174517/
https://europepmc.org/articles/PMC174517/
Autor:
David N. Taylor, Antoinette B. Hartman, C Powell, L L Van De Verg, N O Bendiuk, D B Tang, H H Collins
Publikováno v:
Infection and immunity. 62(2)
This study used the guinea pig keratoconjunctivitis model to examine the importance of route of administration (mucosal versus parenteral), frequency and timing of immunization (primary versus boosting immunization), and form of antigen given (live a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15715345ea212f9e427d8133918cb6c5
https://pubmed.ncbi.nlm.nih.gov/7507892
https://pubmed.ncbi.nlm.nih.gov/7507892
Publikováno v:
Scopus-Elsevier
Protective immunity against shigellosis is thought to be determined by the O-antigen side chains of the lipopolysaccharide (LPS) molecule. To study possible common protective epitopes, monoclonal antibodies reacting with Shigella flexneri 2a LPS were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c4075e1ae8b742410f3601b4bb5de5
http://www.scopus.com/inward/record.url?eid=2-s2.0-0029821866&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0029821866&partnerID=MN8TOARS
Autor:
Schmidt KA; Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC, USA. katherine.a.schmidt@dartmouth.edu, Schneider H, Lindstrom JA, Boslego JW, Warren RA, Van de Verg L, Deal CD, McClain JB, Griffiss JM
Publikováno v:
Sexually transmitted diseases [Sex Transm Dis] 2001 Oct; Vol. 28 (10), pp. 555-64.
Autor:
Schneider H; Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA., Schmidt KA, Skillman DR, Van De Verg L, Warren RL, Wylie HJ, Sadoff JC, Deal CD, Cross AS
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 1996 Jun; Vol. 173 (6), pp. 1422-7.